SiNtx Technologies Inc. (SINT)
NASDAQ: SINTHealthcareMedical DevicesUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
SINT stock chart
Technical analysisKey statistics
All statistics- Market cap
- $14.06M
- EPS (TTM)
- -$4.91
- Dividend yield
- None
- 52-week range
- 1.40 – 4.64
- Day range
- 2.07 – 2.15
- Volume / Avg
- 29.16K / 112.93K
- Beta
- —
- Shares outstanding
- 6.66M
52-week range
SINT stock today
Shares of SiNtx Technologies (SINT) finished lower on Oct 8 at $2.11, a drop of 2.76% or $0.06 per share, versus the S&P 500's 0.47% decline. Trading was light, with 29.16K shares changing hands, about 26% of the average daily volume. At this level, SINT sits in the middle of its 52-week range of $1.40 to $4.64: 54.5% below the high, set on Oct 10, 2025 and 50.7% above the low.
SINT is down 43.8% year to date, underperforming the S&P 500 (+13.5%). Over the past 12 months, the stock has lost 48.5%. SiNtx Technologies has posted a net loss over the last twelve months (EPS of -$4.91), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About SiNtx Technologies
Company profileSintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. The company offers monolithic solid silicon nitride; solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and Polyether Ether Ketone (PEE). The company was formerly known as Amedica Corporation.
- Sector
- Healthcare
- Industry
- Medical Devices
- CEO
- Mr. Eric K. Olson
- Headquarters
- Salt Lake City, UT
- Employees
- 32
- IPO year
- 2014
- Website
- sintx.com
Analyst forecast
ForecastConsensus (4 analysts)
strong_buy
Avg. price target
$9.25+338.39%
- Strong buy 1
- Buy 3
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
SiNtx Technologies peers
Healthcare sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| HSCSHeartSciences Inc. | 3.04 | -12.89% | $14.73M | vs SINT |
| PLSMPulsenmore Ltd. | 1.92 | +0.73% | $12.49M | vs SINT |
| IRIXIRIDEX Corporation | 0.898 | +2.24% | $15.77M | vs SINT |
| CTSOCytosorbents Corporation | 3.73 | -3.62% | $11.75M | vs SINT |
| LFWDLifeward Ltd. | 6.43 | -1.08% | $18.21M | vs SINT |
| NMTCNeuroOne Medical Technologies Corporation | 1.08 | -2.70% | $9.83M | vs SINT |
| AEMDAethlon Medical Inc. | 6.01 | -0.99% | $9.64M | vs SINT |
| TNONTenon Medical Inc. | 3.44 | -1.71% | $9.25M | vs SINT |
Indexes, lists and sector
Appears in lists
SiNtx Technologies stock FAQ
What is SiNtx Technologies's stock price today?
SINT last traded at $2.11 as of Oct 8, 4:00 PM EDT, down 2.76% on the day. Prices are delayed at least 15 minutes.
Does SiNtx Technologies pay a dividend?
No. SiNtx Technologies does not currently pay a regular cash dividend.
Who is SiNtx Technologies's CEO?
Mr. Eric K. Olson is the chief executive officer of SiNtx Technologies Inc., which has about 32 employees.
Has SINT ever split its stock?
Yes. The most recent SINT stock split was a 1-for-200 split on May 28, 2024, one of 4 splits on record.
What is the SINT 52-week high?
The 52-week high for SINT is $4.64 and the 52-week low is $1.40. The stock is currently 54.5% below its high.